Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? (VALIANT Pilot)

This study has been completed.
University of Toronto
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
University Health Network, Toronto Identifier:
First received: August 4, 2010
Last updated: May 10, 2016
Last verified: May 2016